— Know what they know.
Not Investment Advice

H02.SI

Haw Par Corporation Limited
1W: +5.5% 1M: +7.4% 3M: +10.8% YTD: -1.5% 1Y: +58.7% 3Y: +103.1% 5Y: +62.8%
S$16.77 ($13.03)
-0.22 (-1.29%)
 
Weekly Expected Move ±6.4%
S$15 S$16 S$17 S$18 S$19
SES · Healthcare · Drug Manufacturers - General · S$3.7B · Alpha Radar Strong Buy · Power 69
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market CapS$3.7B ($2.9B)
52W Range11.3-17.33
Volume230,500
Avg Volume472,562
Beta0.21
DividendS$0.40
Analyst Ratings
No analyst coverage
Company Info
CEOEe Lim Wee
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2000-01-03
Websitehawpar.com
No. 03-03 Haw Par Technocentre
Singapore 149598
SG
65 6337 9102
About Haw Par Corporation Limited

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms